Skip to content

OSTEOPLASKY CHATELLE

Active
Private limited companyfounded 2006active for 20 yearsWilleriekse dreef 30, 1160 Oudergem, BelgiumKBO/BCE: BE 0879.512.955
Summary

OSTEOPLASKY CHATELLE has been active since 2006 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €41,191 and a net result of €4,244. Equity is shrinking by about 2.6% per year across the filed financial years. Its solvency ranks better than 90% of 20,659 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Activity
Specialist medical practice
NACE 86220
1 site
Size
≈ €51,000turnover 2025, estimated
Equity
€41,191
Profit
€4,244
Turnover estimated from the gross margin
Financial health
95 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Structure
2025 accounts 44 days early1 of 2 deeds summarised
Why 95lowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 16.31, cash €36,498Equity €41,191 (93.9% of total assets)Figures for financial year 2025 (filed 17-06-2026)Show the evidence

Checked score

Score 2025
95 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 60% of its sector peers (NACE 86, micro)
Financial strength · tick = 2024
Strong
Solvency 100=
equity 93.9% of total assets
Liquidity 100=
short-term debt 6.1% · cash 83.2%
Profitability 62-19
return on assets 9.7%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,153 companies, NACE 86, micro)
Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025highest value 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026lowest value 08-2026: < 0.1%● unchanged vs 07-2026lowest value 09-2026: < 0.1%● unchanged vs 08-2026lowest value 10-2026: < 0.1%● unchanged vs 09-2026lowest value
Credit of up to €3,500 on 30-day terms is acceptable
Liquidity ample (current ratio 16.31, compared with 40.28 in 2024, above the usual 1.5; short-term debt: 6.1% and cash: 83.2% of total assets), and 6.1% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 82% on solvency, 95% on liquidity, 10% on profitability and 54% on growth.

The bankruptcy probability was computed on 30-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 16.31, cash €36,498
NBB · annual accounts
lowers risk · Equity €41,191 (93.9% of total assets)
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed 17-06-2026)
NBB · annual accounts
lowers risk · Growing equity
Reported equity is higher than in 2023 and did not fall compared with 2024. These amounts do not establish the cause of the change.
NBB · annual accounts 2025
Equity per financial year
1819202122232425
2018 to 2025 · latest year €41,191
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 17-06-2026, 44 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
44 days early
2024
43 days early
2023
41 days early
2022
40 days early
2021
30 days late
2020
31 days late
2019
92 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 2 days before the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 21 June (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
31-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. Weakest financial yearnet €4,244 ▼34.9%
  3. Annual accounts filedfinancial year 2024 · micro…

Financials · financial year 2025, micro format

Turnover
≈ €51,000
Estimated: probably between €36,000 and €86,000
Total assets
€43,881▲ 15.8%
2024 · €37,888
Net result
€4,244▼ 34.9%
2024 · €6,518
Working capital
€41,191▲ 11.5%
2024 · €36,947
Trend over the years

2021 to 2025, 5 financial years 2018 to 2025, 8 financial years

The operating result falls in 2025; 2025 is 32% below 2024 and is the lowest result in the available series.

What the company sold each financial year and what was left of it. A loss stands below the zero line.

Operating result€6,993 2025 Net result€4,244 2025

Use the arrow keys on the chart for the figures per year.

Sector: the middle half of NACE 86, Human health activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA).

Every figure with its change against the financial year before
favourable unfavourable
Line20182019202020212022202320242025
Operating result€70,761-€66,968▼ 5.4%€36,936▼ 44.8%€35,776▼ 3.1%€9,059▼ 74.7%€7,379▼ 18.5%€10,343▲ 40.2%€6,993▼ 32.4%
Net result€37,678-€49,746▲ 32.0%€27,493within the sector's middle half▼ 44.7%€23,687within the sector's middle half▼ 13.8%€4,742below the sector's middle half▼ 80.0%€4,956below the sector's middle half▲ 4.5%€6,518below the sector's middle half▲ 31.5%€4,244below the sector's middle half▼ 34.9%
Equity€52,806-€62,552▲ 18.5%€32,045below the sector's middle half▼ 48.8%€20,732below the sector's middle half▼ 35.3%€25,474below the sector's middle half▲ 22.9%€30,430below the sector's middle half▲ 19.5%€36,947below the sector's middle half▲ 21.4%€41,191within the sector's middle half▲ 11.5%
Total assets€94,815-€103,309▲ 9.0%€90,903below the sector's middle half▼ 12.0%€55,766below the sector's middle half▼ 38.7%€25,855below the sector's middle half▼ 53.6%€30,552below the sector's middle half▲ 18.2%€37,888below the sector's middle half▲ 24.0%€43,881below the sector's middle half▲ 15.8%
Debt€42,009-€40,757▼ 3.0%€58,858▲ 44.4%€35,034▼ 40.5%€381▼ 98.9%€122▼ 68.0%€941▲ 671%€2,690▲ 186%
Working capital€44,605-€37,613▼ 15.7%€19,501below the sector's middle half▼ 48.2%€20,600below the sector's middle half▲ 5.6%€25,474within the sector's middle half▲ 23.7%€30,430within the sector's middle half▲ 19.5%€36,947within the sector's middle half▲ 21.4%€41,191within the sector's middle half▲ 11.5%
Solvency55.7%-60.5%▲ 4.9pp35.3%within the sector's middle half▼ 25.3pp37.2%within the sector's middle half▲ 1.9pp98.5%above the sector's middle half▲ 61.3pp99.6%above the sector's middle half▲ 1.1pp97.5%above the sector's middle half▼ 2.1pp93.9%above the sector's middle half▼ 3.6pp
Current ratio2.06-1.95▼ 0.111.33below the sector's middle half▼ 0.621.59within the sector's middle half▲ 0.2667.86above the sector's middle half▲ 66.2740.28above the sector's middle half16.31above the sector's middle half▼ 23.96
Return on assets (ROA)39.7%-48.2%▲ 8.4pp30.2%above the sector's middle half▼ 17.9pp42.5%above the sector's middle half▲ 12.2pp18.3%within the sector's middle half▼ 24.1pp16.2%within the sector's middle half▼ 2.1pp17.2%within the sector's middle half▲ 1.0pp9.7%below the sector's middle half▼ 7.5pp
Staff (FTE)0.8-
above within below the middle half of NACE 86, Human health activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30.
Turnover and EBIT margin not published: the micro format does not require them. The turnover shown is an estimate from the gross margin.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Equity and liabilities €43,881
Equity €41,191 ▲ 11.5%
Debt €2,690 ▲ 186%
Debt's share of the balance-sheet total rises from 2.5% to 6.1%. Equity and debt are higher.
Key figures and ratios
2025 value · change against 2024
Debt to equity
0.07▲
2024 · 0.03
ROE
10.3%▼
2024 · 17.6%
Debt ≤ 1 year
€2,690▲
2024 · €941
Income taxes
€2,742▼
2024 · €3,874
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 31,368 companies that looked in July 2024 the way this one looks now, 0.5% went bankrupt within 24 months and 93.5% are still going.

  • Micro
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
0.5% went bankrupt
5.9% stopped otherwise
93.5% still going

A further 0.1% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a bankruptcy probability of < 0.1% over twelve months; the group does not contradict it.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,445 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 31,368 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 37 lines
Balance sheet Code20242025
Assets
Total assets20/58€37,888€43,881▲
Current assets29/58€37,888€43,881▲
Amounts receivable within one year40/41€2,930€5,891▲
Other amounts receivable41€2,930€5,891▲
Cash at bank and in hand54/58€33,597€36,498▲
Deferred charges and accrued income490/1€1,361€1,493▲
Equity and liabilities
Total equity and liabilities10/49€37,888€43,881▲
Equity10/15€36,947€41,191▲
Contributions10/11€18,600€18,600=
Reserves13€8,378€12,622▲
Non-distributable reserves130/1€1,860€1,860=
Reserves not available under the articles1311€1,860€1,860=
Distributable reserves133€6,518€10,762▲
Profit (loss) carried forward14€9,969€9,969=
Amounts payable17/49€941€2,690▲
Amounts payable within one year42/48€941€2,690▲
Trade debts44-€1,585
Suppliers440/4-€1,585
Taxes, remuneration and social security45€652€424▼
Taxes450/3€652€424▼
Other amounts payable47/48€289€681▲
Income statement Code20242025
Other operating charges640/8€899€928▲
Gross operating margin9900€11,241€7,921▼
Operating profit (loss)9901€10,343€6,993▼
Financial income75/76B€94€38▼
Recurring financial income75€94€38▼
Financial charges65/66B€45€45=
Recurring financial charges65€45€45=
Profit (loss) for the period before taxes9903€10,392€6,986▼
Income taxes67/77€3,874€2,742▼
Profit (loss) for the period9904€6,518€4,244▼
Profit (loss) for the period to be appropriated9905€6,518€4,244▼
Appropriation of the result
Profit (loss) to be appropriated9906€16,487€14,213▼
Profit (loss) brought forward from the previous period14P€9,969€9,969=
Transfer to equity691/2€6,518€4,244▼
To the legal reserve6920€6,518-
To other reserves6921-€4,244

The notes to these accounts (3 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20182019202020212022202320242025Change
Non-recurring operating income76A---€4,036-----
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€4,199€15,199€13,457€10,999-----
Other operating charges640/8---€750€793€870€899€928▲ 3.3%
Gross operating margin9900€101,791€113,308€53,976€47,525€9,852€8,249€11,241€7,921▼ 29.5%
Operating profit (loss)9901€70,761€66,968€36,936€35,776€9,059€7,379€10,343€6,993▼ 32.4%
Financial income75/76B---€12-€24€94€38▼ 60.0%
Recurring financial income75€31--€12-€24€94€38▼ 60.0%
Financial charges65/66B---€1,458€66€47€45€45=
Recurring financial charges65€40€40€43€47€66€47€45€45=
Non-recurring financial charges66B---€1,411-----
Profit (loss) for the period before taxes9903€70,752€67,478€36,893€34,330€8,993€7,356€10,392€6,986▼ 32.8%
Income taxes67/77€33,074€17,732€9,400€10,643€4,251€2,400€3,874€2,742▼ 29.2%
Profit (loss) for the period9904€37,678€49,746€27,493€23,687€4,742€4,956€6,518€4,244▼ 34.9%
Profit (loss) for the period to be appropriated9905€37,678€49,746€27,493€23,687€4,742€4,956€6,518€4,244▼ 34.9%
Line20182019202020212022202320242025Change
Assets
Total assets20/58€94,815€103,309€90,903€55,766€25,855€30,552€37,888€43,881▲ 15.8%
Fixed assets21/28€8,201€26,001€12,544€132-----
Intangible fixed assets21€1,277€638-------
Tangible fixed assets22/27€6,792€25,231€12,412€0-----
Financial fixed assets28€132€132€132€132-----
Current assets29/58€86,614€77,308€78,359€55,634€25,855€30,552€37,888€43,881▲ 15.8%
Amounts receivable within one year40/41-€7,550€15,277€8,163€7,300€5,400€2,930€5,891▲ 101%
Other amounts receivable41---€8,163€7,300€5,400€2,930€5,891▲ 101%
Cash at bank and in hand54/58€78,919€66,249€61,554€46,336€17,362€23,868€33,597€36,498▲ 8.6%
Deferred charges and accrued income490/1---€1,135€1,193€1,284€1,361€1,493▲ 9.7%
Equity and liabilities
Total equity and liabilities10/49€94,815€103,309€90,903€55,766€25,855€30,552€37,888€43,881▲ 15.8%
Equity10/15€52,806€62,552€32,045€20,732€25,474€30,430€36,947€41,191▲ 11.5%
Contributions10/11€18,600€18,600-€18,600€18,600€18,600€18,600€18,600=
Reserves13€1,860€1,860€1,860€1,860€1,860€1,860€8,378€12,622▲ 50.7%
Non-distributable reserves130/1---€1,860€1,860€1,860€1,860€1,860=
Reserves not available under the articles1311---€1,860€1,860€1,860€1,860€1,860=
Distributable reserves133------€6,518€10,762▲ 65.1%
Profit (loss) carried forward14€32,346€42,092€11,585€272€5,014€9,970€9,969€9,969=
Amounts payable17/49€42,009€40,757€58,858€35,034€381€122€941€2,690▲ 186%
Amounts payable within one year42/48€42,009€39,695€58,858€35,034€381€122€941€2,690▲ 186%
Trade debts44€1,202€570€858----€1,585-
Suppliers440/4-------€1,585-
Taxes, remuneration and social security45---€10,534--€652€424▼ 34.9%
Taxes450/3---€10,534--€652€424▼ 34.9%
Other amounts payable47/48---€24,500€381€122€289€681▲ 136%
Line20182019202020212022202320242025Change
Profit (loss) for the period9904€37,678€49,746€27,493€23,687€4,742€4,956€6,518€4,244▼ 34.9%
+ Depreciation and write-downs630€4,199€15,199€13,457€10,999-----
Operating cash flow (approximation)€41,877€64,945€40,950€34,686€4,742€4,956€6,518€4,244▼ 34.9%
Investment in fixed assets (approximation)--€32,999€0€1,413-----
Change in cash--€12,670-€4,695-€15,218-€28,974€6,506€9,729€2,901▼ 70.2%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Latest 10 of 20 filings with the National Bank
Financial year Type Filed Reference
31-12-2025 micro format 17-06-2026 2026-00167428
31-12-2024 micro format 18-06-2025 2025-00150164
31-12-2023 micro format 20-06-2024 2024-00145601
31-12-2022 micro format 21-06-2023 2023-00154321
31-12-2021 micro format 30-08-2022 2022-20393662
31-12-2020 micro format 31-08-2021 2021-64200232
31-12-2019 micro format 31-10-2020 2020-66300232
31-12-2018 micro format 31-08-2019 2019-60600200
31-12-2017 micro format 31-07-2018 2018-42500153
31-12-2016 micro format 16-08-2017 2017-43700098

Show all 20 filings

Similar companies · same sector, comparable size

Of the 16,577 active companies whose main activity is specialist medical practice (NACE 86220), figures are known for 8,127. 4,811 are within a factor 10 of this equity. These 5 are the closest to it. See the whole sector

Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.

Directors

Directors
1 director, last change in 2024
CHATELLE Baudouin Jacques Joseph Edouard Ghislain
Director (not named in the articles) · since 05-02-2024
Current
Derived from published Gazette deeds. The KBO keeps the official list of office holders; we do not read it, so the two can differ. See the directors and other office holders in the KBO →
Not every act has been read: a resignation may still be missing
1 of this company's 2 Belgian Official Gazette deeds has not been read yet. Appointments and resignations recorded in them are not yet in the list of directors: someone who resigned there may still be listed as sitting. The acts are in the Timeline.

Mandate history

2 people since 2024, 1 in office
Show
  • Board
  • began earlier
Mandates per person, with start and end dates
Name Functions and periods
CHATELLE Baudouin Jacques Joseph Edouard Ghislain
  • Director (not named in the articles), from 05-02-2024 to date
gérant actuel
  • Manager, until 05-02-2024
See the board, name and registered office on a given date →

Owners and capital

Capital and shareholders

Capital over the years
  1. 05-02-2024 Converted to unavailable equity

Group and network

Connections & network

1 current director
Depth

The network starts from this company’s directors. Other companies they run appear here as nodes.

This company Company Director Shareholding +N: links not shown yet Click a node to look further, drag to arrange, zoom with the mouse wheel.

History

OSTEOPLASKY CHATELLE was incorporated on 21 February 2006.1 Total assets fell from €94,815 in 2018 to €43,881 in 2025.2

  1. 1KBO register
  2. 2National Bank, annual accounts 2018 and 2025

Acts, filings and financial milestones

Next filing, financial year 2026, expected by 31-07-2027
2026
17-06
NBB filing Annual accounts filed
financial year 2025 · micro format
2025
31-12
Financial Weakest financial yearnet €4,244 ▼34.9%
Net result drops to €4,244, the lowest in the series.
18-06
NBB filing Annual accounts filed
financial year 2024 · micro format
2024
20-06
NBB filing Annual accounts filed
financial year 2023 · micro format
05-02
Gazette deed Appointment: CHATELLE Baudouin Jacques Joseph Edouard Ghislain (director)
Resignation: gérant actuel (manager) · Registered office clause · Power of attorney13 facts ▸
  • Director appointment, CHATELLE Baudouin Jacques Joseph Edouard Ghislain (director (not named in the articles))
  • Registered office clause, “1090 Jette,avenue de Jette,312” (deed in French)
  • Power of attorney, CHATELLE Baudouin Jacques Joseph Edouard Ghislain
  • Power of attorney, Nicolas van RAEMDONCK
  • General meeting, 18-12-2023
  • Other provision, “soumission entière au Code des sociétés et des associations, assemblée générale” (deed in French)
  • Legal-form conversion, “société à responsabilité limitée” (deed in French)
  • Capital conversion, “compte de capitaux propres statutairement indisponible” (deed in French)
  • Reserve release, “suppression du compte de capitaux propres statutairement indisponible, fonds disponibles pour distribution” (deed in French)
  • Amendment of the articles
  • Kind of shares, 186, 186
  • Director resignation, gérant actuel (manager)
  • +1 further fact in this act
2023
31-12
Financial Liquidity more than triplescurrent ratio 250.43
Current ratio from 67.86 to 250.43; short-term debt falls from €381 to €122.
21-06
NBB filing Annual accounts filed
financial year 2022 · micro format
2022
31-12
Financial Liquidity more than 42 timescurrent ratio 67.86
Current ratio from 1.59 to 67.86; short-term debt falls from €35,034 to €381.
30-08
NBB filing Annual accounts filed
financial year 2021 · micro format · 30 days late
2021
31-08
NBB filing Annual accounts filed
financial year 2020 · micro format · 31 days late
2020
31-10
NBB filing Annual accounts filed
financial year 2019 · micro format · 92 days late
2019
31-12
Financial Highest result from 2018 to 2025net €49,746 ▲32%
Net result €49,746, the highest in the series.
Show earlier events
31-08
NBB filing Annual accounts filed
financial year 2018 · micro format · 31 days late
2018
31-07
NBB filing Annual accounts filed
financial year 2017 · micro format
2017
16-08
NBB filing Annual accounts filed
financial year 2016 · micro format · 16 days late
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 20 annual accounts filed, the latest 10 are here; all 20 are under Financials.
1 of 2 deeds read
About the unread acts

Of the 2 Belgian Official Gazette deeds we know for this company, 1 has been read. The other one has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Register details

Identification
Legal formPrivate limited company
Founded21-02-2006
Financial year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
70200Business and other management consultancy
Contact
E-mail baudouin.chatelle@c-b-o.orgOudergem
Phone 02.735.46.65Oudergem
E-invoicing
Reachable via Peppol
Peppol ID 0208:0879512955
Registered 21-05-2025

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 30 October 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.

Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.

Sites & property

Location & real-estate footprint
Registered office, Oudergem · 1 establishment unit since 2006
registered office establishment The establishment unit on the map
Ground area
613 m²
Building footprint
366 m²
Building volume
2,024 m³
Parcel 21332E0057/00R004, Brussels · tallest building 6.8 m. Linked by address, not a title deed.
1 establishment unit
Willeriekse dreef 30, 1160 Oudergem
General medical practice
since 2006unit no. 2.228.711.095
1 parcel
Brussels 1 (100%)
Cadastral parcel Region Area Buildings Height / floors
21332E0057/00R004 Brussels 613 m² 1 · 366 m² 6.8 m · 2
How the parcels are linked
Good to know
The parcel matches the address exactly.

Articles of association

What the company does

PurposeThe activities the company may carry out under its articles.
“La pratique et l organisation de l art de soigner et l exercice de l ostéopathie et la kinésithérapie, ainsi que l exercice de toute…” (deed in French)
4 activities (deed in French)
  1. La pratique et l organisation de l art de soigner et l exercice de l ostéopathie et la kinésithérapie, ainsi que l exercice de toute discipline connexe, l exécution de tout acte technique et para-médical, en rapport avec les disciplines et la gestion de tous moyens destinés à en améliorer l exercice
  2. Toutes opérations civiles, mobilières, immobilières ou financières se rattachant directement ou indirectement à son objet ou qui seraient de nature à en faciliter directement ou indirectement, entièrement ou partiellement, la réalisation
  3. Toutes opérations généralement quelconques se rapportant directement ou indirectement à son objet
  4. Se porter caution et donner toute sûreté personnelle ou réelle en faveur de toute personne ou société, liée ou non

The full purpose is in the deed

DurationHow long the company exists; usually unlimited, so until it is dissolved.
Unlimited
Name clauseThe name the company operates under according to its articles.
OSTEOPLASKY CHATELLE
Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
“Simple décision, Région de Bruxelles-Capitale” (deed in French)

deed of 05-02-2024

Who represents it, and how

Who signsWho may bind the company towards others, for example by signing a contract.
“Article 12- Pouvoirs de l'organe d'administration S'il n'y a qu'un seul administrateur, la totalité des pouvoirs d'administration lui est…”
Board ruleHow the board is made up, meets and takes decisions.
“Avec ou sans limitation de durée, organe d administration” (deed in French)
Power of attorneyA special mandate allowing someone to perform one or more acts on the company's behalf.
One provision in the deed

deed of 05-02-2024

Meetings and financial year

Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
Third Tuesday of June at 10:00

deed of 05-02-2024

Other provisionsOther rules from the articles that fall under none of the themes above.

Other provision: “Admission assemblée générale, titulaire titres nominatifs inscrit registre titres nominatifs catégorie concernée” (deed in French)
Other provision: “Procuration écrite à toute personne actionnaire ou non par tout moyen communication, délibérations assemblée générale” (deed in French)
Other provision: “Répartition résultat-réserves, chaque action droit égal répartition bénéfices” (deed in French)
Liquidation distribution: “Biens en nature remis partagés même proportion, actif net réparti proportion nombre actions” (deed in French)
Other provision: “Exécution du mandat au nom et pour compte de la personne morale, représentant permanent de personne morale administrateur ou délégué à la…” (deed in French)
2 more provisions in the deed, see the deed of 05-02-2024

deed of 05-02-2024